Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo)-Reference-Cited by-同舟云学术

Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo)

Published:2022-12 Issue:12 Volume:22 Page:1694-1702
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Deuel Jeremy Werner,Lauria Elisa,Lovey Thibault,Zweifel Sandrine,Meier Mara Isabella,Züst Roland,Gültekin Nejla,Stettbacher Andreas,Schlagenhauf Patricia

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference29 articles.

1. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study;Huang;Lancet,2021

2. Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: a cohort study;Gu;EBioMedicine,2022

3. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study;Lund;Lancet Infect Dis,2021

4. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study;Augustin;Lancet Reg Health Eur,2021

5. The COVID heart-one year after SARS-CoV-2 infection, patients have an array of increased cardiovascular risks;Abbasi;JAMA,2022

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long COVID syndrome: An unfolding enigma;Indian Journal of Medical Research;2024-09-07

2. Reversible effects of the SARS-CoV-2 on semen parameters;Systems Biology in Reproductive Medicine;2024-09

3. WITHDRAWN: COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations;Life Sciences;2024-06

4. Long COVID-associated symptoms prevalent in both SARS-CoV-2 positive and negative individuals: A prospective follow-up study;New Microbes and New Infections;2024-01

5. Reduced HDL-cholesterol in long COVID-19: A key metabolic risk factor tied to disease severity;Clinics;2024-01